Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
EyePoint Pharmaceuticals, Inc. | Other*, 10%+ Owner | Common Stock, $0.001 par value | 3.49M | $87.3M | $25.02 | Sep 1, 2023 | Indirect |
Venus Concept Inc. | Other*, 10%+ Owner | Senior Convertible Preferred Stock | 1.58M | $6.27M | $3.98 | Oct 20, 2023 | I |
Venus Concept Inc. | Other*, 10%+ Owner | Secured Subordinated Convertible Notes | $2M | Jan 18, 2024 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VERO | Venus Concept Inc. | Jan 18, 2024 | 1 | $2M | 4 | Jan 19, 2024 | Other*, 10%+ Owner |
VERO | Venus Concept Inc. | Oct 20, 2023 | 1 | $2M | 4 | Oct 20, 2023 | Other*, 10%+ Owner |
VERO | Venus Concept Inc. | Sep 8, 2023 | 1 | $1M | 4 | Sep 12, 2023 | Other*, 10%+ Owner |
EYPT | EyePoint Pharmaceuticals, Inc. | Sep 1, 2023 | 1 | -$198K | 4/A | Sep 6, 2023 | Other*, 10%+ Owner |
EYPT | EyePoint Pharmaceuticals, Inc. | Aug 30, 2023 | 4 | -$1.47M | 4 | Sep 1, 2023 | Other*, 10%+ Owner |
EYPT | EyePoint Pharmaceuticals, Inc. | Aug 28, 2023 | 3 | -$1.66M | 4 | Aug 30, 2023 | Other*, 10%+ Owner |
EYPT | EyePoint Pharmaceuticals, Inc. | Aug 24, 2023 | 4 | -$2.49M | 4/A | Aug 30, 2023 | Other*, 10%+ Owner |
EYPT | EyePoint Pharmaceuticals, Inc. | Aug 22, 2023 | 2 | -$2.26M | 4 | Aug 24, 2023 | Other*, 10%+ Owner |
VERO | Venus Concept Inc. | Jul 12, 2023 | 1 | $0 | 4 | Jul 13, 2023 | Other*, 10%+ Owner |
VERO | Venus Concept Inc. | May 15, 2023 | 1 | $2M | 4 | May 17, 2023 | Other*, 10%+ Owner |
VERO | Venus Concept Inc. | Nov 18, 2022 | 2 | $3M | 4/A | Nov 22, 2022 | 10%+ Owner |
VERO | Venus Concept Inc. | Dec 15, 2021 | 2 | $4.9M | 4 | Dec 17, 2021 | 10%+ Owner |